Harmonised classification and labelling previous targeted consultations

These targeted consultations for CLH proposals are closed. The consultations are launched in case further information is needed on a particular hazard class, or if comments are sought on e.g. a specific additional document.

The comments received during the consultation are available on the Registry of CLH intentions until outcome.

 

Showing 22 results.
 
(RS)-1-{1-ethyl-4-[4-mesyl-3-(2-methoxyethoxy)-o-toluoyl]pyrazol-5-yloxy}ethyl methyl carbonate; tolpyralate - 1101132-67-5 United Kingdom Carc. 2, H351
STOT RE 2, H373
Aquatic Acute 1, H400, M = 10
Aquatic Chronic 1, H410, M=100
1-isopropyl-4-methylbenzene; p-cymene 202-796-7 99-87-6 Netherlands Flam. Liq. 3, H226,
Acute Tox. 3, H331,
Asp. Tox. 1, H304,
Aquatic Acute 1, H400,
Aquatic Acute 1, M-factor=1,
Aquatic Chronic 3, H412
2-butoxyethanol; ethylene glycol monobutyl ether 203-905-0 111-76-2 603-014-00-0 Article 77(3) request Acute Tox. 4*; H332
Acute Tox. 4*; H312
Acute Tox. 4*; H302
Skin Irrit. 2; H315
Eye Irrit. 2; H319
Acute Tox. 3; H331
Acute Tox. 4; H302
Skin Irrit. 2; H315
Eye Irrit. 2; H319

inhalation: ATE = 3 mg/L
oral: ATE = 1200 mg/kg bw
butanone oxime; ethyl methyl ketoxime; ethyl methyl ketone oxime 202-496-6 96-29-7 Germany Acute Tox. 4*, H312,
Eye Dam. 1, H318,
Skin Sens. 1, H317,
Carc. 2, H351
Acute Tox. 3, H301,
Acute Tox. 4, H312,
Eye Dam. 1, H318,
Skin Sens. 1B, H317,
Carc. 1B, H350,
STOT SE 3, H336
dermal: ATE = 1848 mg/kg
oral: ATE = 100 mg/kg
clomazone (ISO); 2-(2-chlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one 617-258-0 81777-89-1 Denmark Acute Tox. 4, H302,
Acute Tox. 4, H332,
Repr. 1B, H360D,
Aquatic Acute 1, H400,
Aquatic Acute 1, M-factor=1,
Aquatic Chronic 1, H410,
Aquatic Chronic 1, M-factor=1
Copper compounds - - M-factors for long-term aquatic hazard
cypermethrin (ISO); α-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; cypermethrin cis/trans +/- 40/60 257-842-9 52315-07-8 607-421-00-4 Belgium Acute Tox. 4*, H332
Acute Tox. 4*, H302
STOT SE 3, H335
Aquatic Acute 1, H400
Aquatic Chronic 1, H410
Acute Tox. 4*, H332
Acute Tox. 4*, H302
STOT SE 3, H335
Aquatic Acute 1, H400 (M=100000)
Aquatic Chronic 1, H410 (M=1000)
daminozide (ISO); 4-(2,2-dimethylhydrazino)-4-oxobutanoic acid; N-dimethylaminosuccinamic acid 216-485-9 1596-84-5 Czech Republic Carc. 1B, H350
diflufenican (ISO); N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide 617-446-2 83164-33-4 616-032-00-9 United Kingdom Aquatic Chronic 3, H412 Aquatic Acute 1, H400
Aquatic Chronic 1, H410
Flumioxazin (ISO),N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamide - 103361-09-7 613-166-00-X Czech Republic Repr. 1B, H360D,
Aquatic Acute 1, H400,
Aquatic Acute 1, M-factor=1000,
Aquatic Chronic 1, H410,
Aquatic Chronic 1, M-factor=1000
Repr. 2, H361d,
Aquatic Acute 1, H400,
Aquatic Acute 1, M-factor=1000,
Aquatic Chronic 1, H410,
Aquatic Chronic 1, M-factor=1000
hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate; hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate 443-860-6 302776-68-7 607-693-00-4 Germany Aquatic Chronic 4, H413 Aquatic Chronic 1, H410, M-factor = 1000
lead 231-100-4 7439-92-1 082-013-00-1
082-014-00-7
Article 77(3) request Repr. 1A, H360FD
Lact., H362
Repr. 1A, H360FD
Lact., H362
Aquatic Acute 1, H400; M=1
Aquatic Chronic 1, H410; M=10
MCPA-thioethyl (ISO); S-ethyl (4-chloro-2-methylphenoxy)ethanethioate; S-ethyl 4-chloro-o-tolyloxythioacetate 246-831-4 25319-90-8 246-831-4 Poland Acute Tox. 4, H302,
Aquatic Acute 1, M-factor=10,
Aquatic Chronic 1, M-factor=10
methyl methacrylate methyl 2-methylprop-2-enoate methyl 2-methylpropenoate 201-297-1 80-62-6 607-035-00-6 France Flam. Liq. 2, H225
Skin Irrit. 2, H315
Skin Sens. 1, H317
STOT SE 3, H335
Flam. Liq. 2, H225
Skin Irrit. 2, H315
Resp. Sens. 1, H334
Skin Sens. 1, H317
STOT SE 3, H335
N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide; isoflucypram - 1255734-28-1 United Kingdom Acute Tox. 4, H332,
Skin Sens. 1B, H317,
Aquatic Acute 1, H400,
Aquatic Acute 1, M-factor=10,
Aquatic Chronic 1, H410,
Aquatic Chronic 1, M-factor=1
ATE = 2.2 mg/L
N-(hydroxymethyl)acrylamide; methylolacrylamide; [NMA] 213-103-2 924-42-5 France Muta. 1B, H340,
Carc. 1B, H350,
STOT RE 1, H372
N-carboxymethyliminobis(ethylenenitrilo)tetra(acetic acid); Pentapotassium 2,2',2'',2''',2''''-(ethane-1,2-diylnitrilo)pentaacetate; Pentasodium (carboxylatomethyl)iminobis(ethylenenitrilo)tetraacetate
200-652-8
404-290-3
205-391-3
67-43-6
7216-95-7
140-01-2
Commission
pendimethalin (ISO); N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidene 254-938-2 40487-42-1 609-042-00-X Netherlands Skin Sens. 1; H317
Aquatic Acute 1; H400
Aquatic Chronic 1; H410
Repr. 2; H361d
Skin Sens. 1B; H317
Aquatic Acute 1; H400 (M=100)
Aquatic Chronic 1; H410 (M=10)
prothioconazole (ISO); 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2,4-dihydro-3H-1,2,4-triazole-3-thione - 178928-70-6 United Kingdom Aquatic Acute 1, H400,
Aquatic Chronic 1, H410
pyrithione zinc; (T-4)-bis[1-(hydroxy-.kappa.O)pyridine-2(1H)-thionato-.kappa.S]zinc 236-671-3 13463-41-7 Sweden Acute Tox. 3, H301
Acute Tox. 2, H330
Eye Dam. 1, H318
Repr. 1B, H360D
STOT RE 1, H372
Aquatic Acute 1, H400
Aquatic Acute 1, M-factor=1000
Aquatic Chronic 1, H410
Aquatic Chronic 1, M-factor=10
pyrithione zinc; (T-4)-bis[1-(hydroxy-.kappa.O)pyridine-2(1H)-thionato-.kappa.S]zinc 236-671-3 13463-41-7 Sweden Acute Tox. 3, H301,
Acute Tox. 2, H330,
Eye Dam. 1, H318,
Repr. 1B, H360D,
STOT RE 1, H372,
Aquatic Acute 1, H400,
M-factor=1000,
Aquatic Chronic 1, H410,
M-factor=10
Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-, hydrolysis products with silica 272-697-1 68909-20-6 France STOT RE 2, H373;
Acute Tox. 2, H330
ATE = 0.45 mg/L (dusts and mists)
Showing 22 results.



Categories Display

Tagged as:

(click the tag to search for relevant content)